Cargando…
Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation
Neuroendocrine differentiation of prostate cancer (NEDPC) includes de novo presentation and secondary to epigenetic changes, referred as therapy-induced neuroendocrine prostate cancer (t-NEPC). Molecular imaging with prostate-specific membrane antigen (PSMA) and somatostatin analogues positron emiss...
Autores principales: | Vargas Ahumada, Joel, González Rueda, Sofía D., Sinisterra Solís, Fabio A., Pitalúa Cortés, Quetzali, Torres Agredo, Liliana P., Miguel, Jimenez Ríos, Scavuzzo, Anna, Soldevilla-Gallardo, Irma, Álvarez Avitia, Miguel A., Sobrevilla, Nora, García Pérez, Francisco Osvaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221809/ https://www.ncbi.nlm.nih.gov/pubmed/35741197 http://dx.doi.org/10.3390/diagnostics12061387 |
Ejemplares similares
-
Head-to-Head Comparison of (68)Ga-PSMA-11 and (131)I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent
por: Pitalua-Cortes, Quetzali, et al.
Publicado: (2021) -
(68)Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer
por: Pitalúa-Cortés, Quetzali Gabriela, et al.
Publicado: (2017) -
Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer
por: Bello, Thomas, et al.
Publicado: (2021) -
Divergent clonal evolution of castration resistant neuroendocrine prostate cancer
por: Beltran, Himisha, et al.
Publicado: (2016) -
Exploring BenzylethoxyAryl Urea Scaffolds for Multitarget Immunomodulation Therapies
por: Gil-Edo, Raquel, et al.
Publicado: (2023)